ClinicalTrials.Veeva

Menu

The COMPASSION Study

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Enrolling

Conditions

Breast Cancer
Unresectable Breast Carcinoma
Metastatic Breast Cancer
Advanced Breast Cancer

Treatments

Other: Telehealth Hospice Visits

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Full description

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Study procedures include giving verbal consent to participate and a one-time survey delivered by email or phone call.

About 200 people, which includes 50 participants, 50 caregivers, 50 hospice nurses, and about 50 oncology providers, are expected to participate in this research study.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient of any gender with unresectable locally advanced or metastatic breast cancer
  • Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice </= 1 week before enrollment
  • Ability to conduct video or phone check-ins, even if assistance required.
  • Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
  • Hospice setting is within Massachusetts
  • Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team
  • Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment

Exclusion criteria

  • Unable to provide verbal consent
  • Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
  • Hospice setting outside of Massachusetts
  • Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Usual Care Cohort
No Intervention group
Description:
25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone.
Compassion Cohort
Experimental group
Description:
25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone. * 4 weekly check-ins via Zoom or phone call with study team.
Treatment:
Other: Telehealth Hospice Visits

Trial contacts and locations

1

Loading...

Central trial contact

Claire Smith, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems